Graeber M | MDedge

A North American Study of Adapalene–Benzoyl Peroxide Combination Gel in the Treatment of Acne

Article Type

Changed

Thu, 01/10/2019 - 12:18

Display Headline

A North American Study of Adapalene–Benzoyl Peroxide Combination Gel in the Treatment of Acne

Author(s)

Article PDF

Author and Disclosure Information

Stein Gold L, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; for Adapalene-BPO Study Group

Issue

Cutis - 84(2)

Publications

MDedge Dermatology

Topics

Page Number

110-116

Read more about A North American Study of Adapalene–Benzoyl Peroxide Combination Gel in the Treatment of Acne

Sections

Original Research

Author(s)

Author(s)

Author and Disclosure Information

Stein Gold L, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; for Adapalene-BPO Study Group

Author and Disclosure Information

Stein Gold L, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; for Adapalene-BPO Study Group

Article PDF

Article PDF

Issue

Cutis - 84(2)

Issue

Cutis - 84(2)

Page Number

110-116

Page Number

110-116

Publications

MDedge Dermatology

Publications

MDedge Dermatology

Topics

Article Type

Display Headline

A North American Study of Adapalene–Benzoyl Peroxide Combination Gel in the Treatment of Acne

Display Headline

A North American Study of Adapalene–Benzoyl Peroxide Combination Gel in the Treatment of Acne

Sections

Original Research

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Article Type

Changed

Thu, 01/10/2019 - 12:05

Display Headline

The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Author(s)

Article PDF

Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Issue

Cutis - 76(2)

Publications

MDedge Dermatology

Topics

Page Number

145-151

Read more about The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Sections

Original Research

Author(s)

Author(s)

Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Article PDF

Article PDF

Issue

Cutis - 76(2)

Issue

Cutis - 76(2)

Page Number

145-151

Page Number

145-151

Publications

MDedge Dermatology

Publications

MDedge Dermatology

Topics

Article Type

Display Headline

The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Display Headline

The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Sections

Original Research

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Article Type

Changed

Thu, 01/10/2019 - 12:00

Display Headline

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Author(s)

Article PDF

Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Issue

Cutis - 73(1)

Publications

MDedge Dermatology

Topics

Contact Dermatitis

Page Number

31-38

Read more about Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Sections

Original Research

Author(s)

Author(s)

Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Article PDF

Article PDF

Issue

Cutis - 73(1)

Issue

Cutis - 73(1)

Page Number

31-38

Page Number

31-38

Publications

MDedge Dermatology

Publications

MDedge Dermatology

Topics

Contact Dermatitis

Article Type

Display Headline

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Display Headline

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Sections

Original Research

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Subscribe to Graeber M